36 results on '"Chen, Yan"'
Search Results
2. Correlation of Gut Microbiota with Children Obesity and Weight Loss
- Author
-
Peng, Li-Jun, Chen, Yan-Ping, Qu, Fang, Zhong, Yan, and Jiang, Zhi-Sheng
- Published
- 2024
- Full Text
- View/download PDF
3. Gut microbiota dysbiosis in ankylosing spondylitis: a systematic review and meta-analysis
- Author
-
Qin-Yi Su, Yan Zhang, Dan Qiao, Xia Song, Yang Shi, Zhe Wang, Chen-Yan Wang, and Sheng-Xiao Zhang
- Subjects
ankylosing spondylitis ,gut microbiota ,dysbiosis ,α-diversity ,meta-analysis ,Microbiology ,QR1-502 - Abstract
BackgroundAnkylosing spondylitis (AS) is a connective tissue disease that primarily affects spinal joints, peripheral joints, and paravertebral soft tissues, leading to joint stiffness and spinal deformity. Growing evidence has implicated gut microbiota in the regulation of AS, though the underlying mechanisms remain poorly understood.MethodsWe conducted a comprehensive search of PubMed, Embase, Web of Science, the Cochrane Library, MEDLINE, Wanfang Data, China Science and Technology Journal Database (VIP), and China National Knowledge Internet (CNKI) databases from the time the databases were created until 30 July 2023. To evaluate changes in α-diversity and the abundance of certain microbiota families in AS, standardized mean difference (SMD) and 95% confidence interval (CI) calculations were made. Meta-analyses were performed using STATA 12.0 and the quality of the literature was assessed by following systematic review guidelines.ResultsThis systematic review and meta-analysis included 47 studies, providing insights into the gut microbiota composition in patients with AS compared to healthy controls (HCs). Our findings indicate a significant reduction in gut microbial diversity in patients with AS, as evidenced by a decrease in both richness and evenness. Specifically, the Shannon index showed a moderate decrease (SMD = -0.27, 95% CI: -0.49, -0.04; P < 0.001), suggesting a less diverse microbial ecosystem in patients with AS. The Chao1 index further confirmed this trend, with a larger effect size (SMD = -0.44, 95% CI: -0.80, -0.07; P < 0.001), indicating a lower species richness. The Simpson index also reflected a significant reduction in evenness (SMD = -0.30, 95% CI: -0.53, -0.06; P < 0.001). Additionally, patients with AS who received anti-rheumatic combination treatment exhibited a more pronounced reduction in α-diversity compared to untreated patients, highlighting the potential impact of this treatment on gut microbiota balance. In terms of specific microbial families, we observed a significant decrease in the abundance of Bifidobacterium (SMD = -0.42, 95% CI: -2.37, 1.52; P < 0.001), which is known for its beneficial effects on gut health. Conversely, an increase in the abundance of Bacteroidetes was noted (SMD = 0.42, 95% CI: -0.93, 1.76; P < 0.001), suggesting a possible shift in the gut microbiota composition that may be associated with AS pathophysiology.ConclusionOur analysis revealed changes in α-diversity and the relative abundance of specific bacteria in AS. This suggests that targeting the gut microbiota could provide new therapeutic opportunities for treating AS.Systematic review registrationhttps://www.crd.york.ac.uk./PROSPERO/, identifier CRD42023450028.
- Published
- 2024
- Full Text
- View/download PDF
4. Effect of gastrodin against cognitive impairment and neurodegeneration in APP/PS1 mice via regulating gut microbiota–gut–brain axis
- Author
-
Zhang, Yuhe, Chen, Yan, Yuan, Shushu, Yu, Qingxia, Fu, Jianjiong, Chen, Luyun, Liu, Jiaming, and He, Yuping
- Published
- 2023
- Full Text
- View/download PDF
5. Impact of probiotics supplement on the gut microbiota in neonates with antibiotic exposure: an open-label single-center randomized parallel controlled study
- Author
-
Zhong, Hui, Wang, Xiang-Geng, Wang, Jing, Chen, Yan-Jie, Qin, Huan-Long, and Yang, Rong
- Published
- 2021
- Full Text
- View/download PDF
6. Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study.
- Author
-
Yang, Wenjing, Fan, Xinxia, Li, Wangshu, and Chen, Yan
- Subjects
SMALL cell lung cancer ,GUT microbiome ,LUNG cancer ,GENETIC variation - Abstract
Background: Previous studies have hinted at a significant link between lung cancer and the gut microbiome, yet their causal relationship remains to be elucidated. Methods: GWAS data for small cell lung cancer (SCLC) was extracted from the FinnGen consortium, comprising 179 cases and 218 613 controls. Genetic variation data for 211 gut microbiota were obtained as instrumental variables from MiBioGen. Mendelian randomization (MR) was employed to determine the causal relationship between the two, with inverse variance weighting (IVW) being the primary method for causal analysis. The MR results were validated through several sensitivity analyses. Results: The study identified a protective effect against SCLC for the genus Eubacterium ruminantium group (OR = 0.413, 95% CI: 0.223–0.767, p = 0.00513), genus Barnesiella (OR = 0.208, 95% CI: 0.0640–0.678, p = 0.00919), family Lachnospiraceae (OR = 0.319, 95% CI: 0.107–0.948, p = 0.03979), and genus Butyricimonas (OR = 0.376, 95% CI: 0.144–0.984, p = 0.04634). Conversely, genus Intestinibacter (OR = 3.214, 95% CI: 1.303–7.926, p = 0.01125), genus Eubacterium oxidoreducens group (OR = 3.391, 95% CI: 1.215–9.467, p = 0.01973), genus Bilophila (OR = 3.547, 95% CI: 1.106–11.371, p = 0.03315), and order Bacillales (OR = 1.860, 95% CI: 1.034–3.347, p = 0.03842) were found to potentially promote the onset of SCLC. Conclusion: We identified potential causal relationships between certain gut microbiota and SCLC, offering new insights into microbiome‐mediated mechanisms of SCLC pathogenesis, resistance, mutations, and more. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Association between premature ovarian insufficiency and gut microbiota
- Author
-
Wu, Jiaman, Zhuo, Yuanyuan, Liu, Yulei, Chen, Yan, Ning, Yan, and Yao, Jilong
- Published
- 2021
- Full Text
- View/download PDF
8. Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling
- Author
-
Yun Li, Huiqin Hou, Xianglu Wang, Xin Dai, Wanru Zhang, Qiang Tang, Yue Dong, Chen Yan, Bangmao Wang, Zhengxiang Li, and Hailong Cao
- Subjects
diammonium glycyrrhizinate ,obesity ,gut microbiota ,bile acids ,farnesoid X-activated receptor ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Obesity is a worldwide epidemic metabolic disease. Gut microbiota dysbiosis and bile acids (BAs) metabolism disorder are closely related to obesity. Farnesoid X-activated receptor (FXR), served as a link between gut microbiota and BAs, is involved in maintaining metabolic homeostasis and regulating glucose and lipid metabolism. We previously reported that diammonium glycyrrhizinate (DG) could alter gut microbiota and prevent non-alcoholic fatty liver disease. However, it remains ambiguous how DG affects the gut microbiota to regulate host metabolism. In this present study, 16S rRNA Illumina NovaSeq and metabolomic analysis revealed that DG treatment suppressed microbes associated with bile-salt hydrolase (BSH) activity, which, in turn, increased the levels of taurine-conjugated BAs accompanied by inhibition of ileal FXR-FGF15 signaling. As a result, several obesity-related metabolism were improved, like lower serum glucose and insulin levels, increased insulin sensitivity, few hepatic steatosis and resistance to weight gain. Additionally, decreased level of serum lipopolysaccharide was observed, which contributed to a strengthened intestinal barrier. The effect of DG on weight loss was slightly enhanced in the antibiotics-treated obese mice. Collectively, the efficacy of DG in the treatment of obesity might depend on gut microbiota-conjugated BAs-FXR axis. Hence, it will provide a potential novel approach for the treatment of obesity.
- Published
- 2021
- Full Text
- View/download PDF
9. Preventive Effect of the Total Polyphenols from Nymphaea candida on Sepsis-Induced Acute Lung Injury in Mice via Gut Microbiota and NLRP3, TLR-4/NF-κB Pathway.
- Author
-
Li, Chenyang, Qi, Xinxin, Xu, Lei, Sun, Yuan, Chen, Yan, Yao, Yuhan, and Zhao, Jun
- Subjects
GUT microbiome ,NEUTROPHILS ,LUNG injuries ,NLRP3 protein ,POLYPHENOLS ,TIGHT junctions - Abstract
This study aimed to investigate the preventive effects of the total polyphenols from Nymphaea candida (NCTP) on LPS-induced septic acute lung injury (ALI) in mice and its mechanisms. NCTP could significantly ameliorate LPS-induced lung tissue pathological injury in mice as well as lung wet/dry ratio and MPO activities (p < 0.05). NCTP could significantly decrease the blood leukocyte, neutrophil, monocyte, basophil, and eosinophil amounts and LPS contents in ALI mice compared with the model group (p < 0.05), improving lymphocyte amounts (p < 0.05). Moreover, compared with the model group, NCTP could decrease lung tissue TNF-α, IL-6, and IL-1β levels (p < 0.05) and downregulate the protein expression of TLR4, MyD88, TRAF6, IKKβ, IκB-α, p-IκB-α, NF-κB p65, p-NF-κB p65, NLRP3, ASC, and Caspase1 in lung tissues (p < 0.05). Furthermore, NCTP could inhibit ileum histopathological injuries, restoring the ileum tight junctions by increasing the expression of ZO-1 and occludin. Simultaneously, NCTP could reverse the gut microbiota disorder, restore the diversity of gut microbiota, increase the relative abundance of Clostridiales and Lachnospiraceae, and enhance the content of SCFAs (acetic acid, propionic acid, and butyric acid) in feces. These results suggested that NCTP has preventive effects on septic ALI, and its mechanism is related to the regulation of gut microbiota, SCFA metabolism, and the TLR-4/NF-κB and NLRP3 pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Gut Microbiota Dysbiosis and Inflammation Dysfunction in Late-Life Depression: An Observational Cross-Sectional Analysis.
- Author
-
Chen, Yan, Le, Dansheng, Xu, Jiaxi, Jin, Piaopiao, Zhang, Yuhan, and Liao, Zhengluan
- Subjects
- *
GUT microbiome , *DYSBIOSIS , *CROSS-sectional method , *INFLAMMATION , *MENTAL depression - Abstract
Purpose: There are some challenges to diagnosis in the context of similar diagnostic criteria for late-life depression (LLD) and adult depression due to cognitive impairment and other clinical manifestations. The association between gut microbiota and inflammation remains unclear in LLD. We analyzed gut microbiota characteristics and serum inflammatory cytokines in individuals with LLD to explore the combined role of these two factors in potential biomarkers of LLD. Methods: This was an observational cross-sectional study. Fecal samples and peripheral blood from 29 patients and 33 sex- and age-matched healthy controls (HCs) were collected to detect gut microbiota and 12 inflammatory factors. We analyzed differences in diversity and composition of gut microbiota and evaluated relations among gut microbiota, inflammatory factors, and neuropsychological scales. We extracted potential biomarkers using receiver-operating characteristic curve analysis to predict LLD utilizing the combination of the microbiota and inflammatory cytokines. Results: Elevated systemic inflammatory cytokine levels and gut microbiota dysbiosis were found in LLD patients. Relative abundance of Verrucomicrobia at the phylum level and Megamonas, Citrobacter, and Akkermansia at the genus level among LLD patients was lower than HCs. Abundance of Coprococcus, Lachnobacterium, Oscillospira, and Sutterella was higher in LLD patients. Notably, IL6, IFNγ, Verrucomicrobia, and Akkermansia levels were correlated with depression severity. Our study identified IL6, Akkermansia, and Sutterella as predictors of LLD, and their combination achieved an area under the curve of 0.962 in distinguishing LLD patients from HCs. Conclusion: This research offers evidence of changes within gut microbiota and systemic inflammation in LLD. These findings possibly help elucidate functions of gut microbiota and systemic inflammation in LLD development and offer fresh ideas on biomarkers for clinical practise in the context of LLD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Characterization of gut microbiota associated with clinical parameters in intrahepatic cholestasis of pregnancy
- Author
-
Li, Rong, Chen, Xuehai, Liu, Zhongzhen, Chen, Yan, Liu, Chuan, Ye, Lingfei, Xiao, Liang, Yang, Zhenjun, He, Jian, Wang, Wen-Jing, and Qi, Hongbo
- Published
- 2020
- Full Text
- View/download PDF
12. Intermittent administration of a fasting-mimicking diet intervenes in diabetes progression, restores β cells and reconstructs gut microbiota in mice
- Author
-
Wei, Siying, Han, Ruomei, Zhao, Jingyu, Wang, Shuo, Huang, Meiqin, Wang, Yining, and Chen, Yan
- Published
- 2018
- Full Text
- View/download PDF
13. Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE−/− mice
- Author
-
Chan, Yee Kwan, El-Nezami, Hani, Chen, Yan, Kinnunen, Kristiina, and Kirjavainen, Pirkka V.
- Published
- 2016
- Full Text
- View/download PDF
14. Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections
- Author
-
Xue Zhang, Chen Yan, Yinling Liu, Dazhong Yan, Na Li, and Yanzhen Li
- Subjects
Gastrointestinal Diseases ,medicine.drug_class ,Antibiotics ,Pharmaceutical Science ,enteric infection ,antimicrobial mechanisms of chitosan ,Organic chemistry ,Review ,Colonisation resistance ,macromolecular substances ,Analytical Chemistry ,Microbiology ,Chitosan ,chemistry.chemical_compound ,Antibiotic resistance ,QD241-441 ,Anti-Infective Agents ,Antimicrobial polymer ,colonization resistance ,Drug Discovery ,Generally recognized as safe ,medicine ,Humans ,Physical and Theoretical Chemistry ,gut microbiota ,technology, industry, and agriculture ,Bacterial Infections ,Antimicrobial ,equipment and supplies ,Anti-Bacterial Agents ,carbohydrates (lipids) ,antibacterial ,chemistry ,Chemistry (miscellaneous) ,drug delivery ,Drug delivery ,Nanoparticles ,Molecular Medicine ,antimicrobial ,chitosan ,antifungal - Abstract
Antibiotics played an important role in controlling the development of enteric infection. However, the emergence of antibiotic resistance and gut dysbiosis led to a growing interest in the use of natural antimicrobial agents as alternatives for therapy and disinfection. Chitosan is a nontoxic natural antimicrobial polymer and is approved by GRAS (Generally Recognized as Safe by the United States Food and Drug Administration). Chitosan and chitosan derivatives can kill microbes by neutralizing negative charges on the microbial surface. Besides, chemical modifications give chitosan derivatives better water solubility and antimicrobial property. This review gives an overview of the preparation of chitosan, its derivatives, and the conjugates with other polymers and nanoparticles with better antimicrobial properties, explains the direct and indirect mechanisms of action of chitosan, and summarizes current treatment for enteric infections as well as the role of chitosan and chitosan derivatives in the antimicrobial agents in enteric infections. Finally, we suggested future directions for further research to improve the treatment of enteric infections and to develop more useful chitosan derivatives and conjugates.
- Published
- 2021
15. Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice
- Author
-
Xin Dai, Qijin He, Chen Yan, Jingyue Zhang, Bangmao Wang, Lu Zhou, Hengjie Yuan, Maojuan Ran, Ling Liang, Lu Zhang, Xin Chen, Jie Zhang, Chenxi Lou, Siyuan Sun, Xiuxiu Xu, and Jingwen Zhao
- Subjects
medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,AHR ,sulforaphane ,Inflammation ,Gut flora ,Proinflammatory cytokine ,chemistry.chemical_compound ,Downregulation and upregulation ,Internal medicine ,NAFLD ,medicine ,TX341-641 ,Nutrition ,Original Research ,Nutrition and Dietetics ,biology ,gut microbiota ,Nutrition. Foods and food supply ,Chemistry ,food and beverages ,Lipid metabolism ,Aryl hydrocarbon receptor ,biology.organism_classification ,medicine.disease ,Endocrinology ,high-fat diet ,biology.protein ,lipids (amino acids, peptides, and proteins) ,indole-3-acetic acid ,medicine.symptom ,Steatosis ,Food Science ,Sulforaphane - Abstract
Scope: Gut microbiome-derived metabolites are the major mediators of diet-induced host-microbial interactions. Aryl hydrocarbon receptor (AHR) plays a crucial role in glucose, lipid, and cholesterol metabolism in the liver. In this study, we aimed to investigate the role of indole-3-acetic acid (IAA) and AHR in sulforaphane (SFN) alleviates hepatic steatosis in mice fed on a high-fat diet (HFD).Methods and Results: The HFD-fed male C57BL/6 mice were intervened with SFN for 6 weeks. HFD-mice showed classical pathophysiological characteristics of hepatic steatosis. The results showed that SFN significantly reduced body weight, liver inflammation and hepatic steatosis in HFD-fed mice. SFN reduced hepatic lipogenesis by activating AHR/SREBP-1C pathway, which was confirmed in HepG2 cell experiments. Moreover, SFN increased hepatic antioxidant activity by modulating Nrf-2/NQO1 expression. SFN increased serum and liver IAA level in HFD mice. Notably, SFN manipulated the gut microbiota, resulting in reducing Deferribacteres and proportions of the phylum Firmicutes/Bacteroidetes and increasing the abundance of specific bacteria that produce IAA. Furthermore, SFN upregulated Ahr expression and decreased the expression of inflammatory cytokines in Raw264.7 cells.Conclusions: SFN ameliorated hepatic steatosis not only by modulating lipid metabolism via AHR/SREBP-1C pathway but regulating IAA and gut microbiota in HFD-induced NAFLD mice.
- Published
- 2021
16. Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice.
- Author
-
Huang, Yuzhe, Chen, Hao, Chen, Jielin, Wu, Qingxi, Zhang, Wenna, Li, Daxiang, Lu, Yongming, and Chen, Yan
- Abstract
Nonalcoholic fatty liver disease (NAFLD) is a major clinical and global public health issue, with no specific pharmacological treatment available. Currently, there is a lack of approved drugs for the clinical treatment of NAFLD. Large-leaf yellow tea polysaccharides (YTP) is a natural biomacromolecule with excellent prebiotic properties and significant therapeutic effects on multiple metabolic diseases. However, the specific mechanisms by which YTP regulates NAFLD remain unclear. This study aims to explore the prebiotic effects of YTP and the potential mechanisms by which it inhibits hepatic cholesterol accumulation in NAFLD mice. The effects of YTP on lipid accumulation were evaluated in NAFLD mice through obesity trait analysis and bile acids (BAs) metabolism assessment. Additionally, fecal microbiota transplantation (FMT) was performed, and high-throughput sequencing was employed to investigate the mechanisms underlying YTP's regulatory effects on gut microbiota and BA metabolism. Our study demonstrated that YTP altered the constitution of colonic BA, particularly increasing the levels of conjugated BA and non-12OH BA, which suppressed ileum FXR receptors and hepatic BA reabsorption, facilitated BA synthesis, and fecal BA excretion. The modifications were characterized by a decrease in the levels of FXR, FGF15, FGFR4, and ASBT proteins, and an increase in the levels of Cyp7a1 and Cyp27a1 proteins. YTP might affect enterohepatic circulation and by the activated the hepatic FXR-SHP pathway. Meanwhile, YTP reshaped the intestinal microbiome structure by decreasing BSH-producing genera and increasing taurine metabolism genera. The correlation analysis implied that Muribaculaceae, Pseudomonas, acterium_coprostanoligenes_group, Clostridiales, Lachnospiraceae_NK4A136_group, Delftia, Dubosiella, and Romboutsia were strongly correlated with specific BA monomers. YTP modulates bile salt hydrolase-related microbial genera to activate alternative bile acid synthesis pathways, thereby inhibiting NAFLD progression. These results suggest that YTP may serve as a potential probiotic formulation, offering a feasible dietary intervention for NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Opportunities and Challenges for Gut Microbiota in Acute Leukemia.
- Author
-
Ma, Tao, Chen, Yan, Li, Li-Juan, and Zhang, Lian-Sheng
- Subjects
GUT microbiome ,ACUTE leukemia ,HEMATOPOIETIC stem cell transplantation ,PROGNOSIS ,HEMATOLOGIC malignancies ,IMMUNOLOGIC diseases ,INFECTION - Abstract
Acute leukemia (AL) is a highly heterogeneous hematologic malignancy, and although great progress has been made in the treatment of AL with allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and new targeted drugs, problems such as infection and GVHD in AL treatment are still serious. How to reduce the incidence of AL, improve its prognosis and reduce the side effects of treatment is a crucial issue. The gut microbiota plays an important role in regulating disease progression, pathogen colonization, and immune responses. This article reviews recent advances in the gut microbiota and AL pathogenesis, infection, treatment and its role in allo-HSCT. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Total Flavonoids of Glycyrrhiza uralensis Alleviates Irinotecan-Induced Colitis via Modification of Gut Microbiota and Fecal Metabolism.
- Author
-
Yue, Shi-Jun, Qin, Yi-Feng, Kang, An, Tao, Hui-Juan, Zhou, Gui-Sheng, Chen, Yan-Yan, Jiang, Jian-Qin, Tang, Yu-Ping, and Duan, Jin-Ao
- Subjects
GUT microbiome ,GLYCYRRHIZA ,COLITIS ,FLAVONOIDS ,WEIGHT loss - Abstract
Irinotecan (CPT-11)-induced gastrointestinal toxicity strongly limits its anticancer efficacy. Glycyrrhiza uralensis Fisch., especially flavonoids, has strong anti-inflammatory and immunomodulatory activities. Herein, we investigate the protective effect of the total flavonoids of G. uralensis (TFGU) on CPT-11–induced colitis mice from the perspective of gut microbiota and fecal metabolism. The body weight and colon length of mice were measured. Our results showed that oral administration of TFGU significantly attenuated the loss of body weight and the shortening of colon length induced by CPT-11. The elevated disease activity index and histological score of colon as well as the up-regulated mRNA and protein levels of TNF-α, IL-1β, and IL-6 in the colonic tissue of CPT-11–treated mice were significantly decreased by TFGU. Meanwhile, TFGU restored the perturbed gut microbial structure and function in CPT-11–treated mice to near normal level. TFGU also effectively reversed the CPT-11–induced fecal metabolic disorders in mice, mainly call backing the hypoxanthine and uric acid in purine metabolism. Spearman's correlation analysis further revealed that Lactobacillus abundance negatively correlated with fecal uric acid concentration, suggesting the pivotal role of gut microbiota in CPT-11–induced colitis. Since uric acid is a ligand of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, TFGU was further validated to inhibit the activation of NLRP3 inflammasome by CPT-11. Our findings suggest TFGU can correct the overall gut microbial dysbiosis and fecal metabolic disorders in the CPT-11–induced colitis mice, underscoring the potential of using dietary G. uralensis as a chemotherapeutic adjuvant. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Metagenome Sequencing Reveals the Midgut Microbiota Makeup of Culex pipiens quinquefasciatus and Its Possible Relationship With Insecticide Resistance.
- Author
-
Wang, Yi-ting, Shen, Rui-xin, Xing, Dan, Zhao, Chen-pei, Gao, He-ting, Wu, Jia-hong, Zhang, Ning, Zhang, Heng-duan, Chen, Yan, Zhao, Tong-yan, and Li, Chun-xiao
- Subjects
CULEX quinquefasciatus ,INSECTICIDE resistance ,ENTEROBACTER cloacae ,PRINCIPAL components analysis ,METAGENOMICS ,BACILLUS cereus ,ENTEROBACTER ,MOSQUITO control - Abstract
Midgut microbiota can participate in the detoxification and metabolism processes in insects, but there are few reports on the relationship between midgut microbiota and insecticide resistance in mosquitoes. In this study, we performed metagenomic sequencing on a susceptible strain (SS), a field-collected Hainan strain (HN), and a deltamethrin-resistant strain (RR) of Culex pipiens quinquefasciatus to understand the diversity and functions of their midgut microbiota. The results revealed differences in midgut microbiota among the three strains of Cx. pipiens quinquefasciatus. At the phylum level, Proteobacteria was the most prominent, accounting for nearly 70% of their midgut microbes. At the genus level, Aeromonas made up the highest proportion. In addition, Aeromonas , Morganella , Elizabethkingia , Enterobacter , Cedecea , and Thorsellia showed significant differences between strains. At the species level, Bacillus cereus , Enterobacter cloacae complex sp. 4DZ3-17B2, Streptomyces sp. CNQ329, and some species of Pseudomonas and Wolbachia were more abundant in the two resistant strains. Principal component analysis (PCA) showed that the SS strain had significantly different metagenomic functions than the two deltamethrin-resistant strains (HN and RR strain). The HN and RR strains differed from the SS strain in more than 10 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The analysis of species abundance and functional diversity can provide directions for future studies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Parasutterella, in association with irritable bowel syndrome and intestinal chronic inflammation.
- Author
-
Chen, Yan‐Jie, Wu, Hao, Wu, Sheng‐Di, Lu, Nan, Wang, Yi‐Ting, Liu, Hai‐Ning, Dong, Ling, Liu, Tao‐Tao, and Shen, Xi‐Zhong
- Subjects
- *
IRRITABLE colon , *GASTROINTESTINAL diseases , *INFLAMMATION , *LYMPHOCYTES , *GENE expression - Abstract
Background and Aim: Irritable bowel syndrome (IBS) is a highly prevalent chronic functional gastrointestinal disorder. Recent studies have showed increasing important role of gut microbiota in the pathophysiological changes of IBS. Our study aims to elaborate the association between intestinal flora with the genesis and the development of IBS. Methods: Illumina high‐throughput sequencing technology was applied to investigate microbial communities of IBS patients and healthy donors. Stool specimens from the IBS‐D patients were equally premixed and implanted into germ free C57B/6 mice to construct IBS animal model, and the normal group was also transplanted with normal premixed feces. The post‐transplant defecation and intra‐epithelial lymphocyte counts were evaluated. Microbial communities were also checked by the illumina high‐throughput sequencing technology. Results: Fifteen genuses significantly different were found expressed in the gut flora of IBS patients, and six genuses showed significantly different abundances between the stool specimens of mice of IBS group and normal group. Among these differences, Parasutterella expression was remarkably different in both screening and validation experiments and also related to chronic intestinal inflammation; therefore, Parasutterella expression is considered in association with the development and progression of IBS. Conclusion: Parasutterella may be related with the genesis and development of IBS and also associated with chronic intestinal inflammation in IBS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
21. Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men: study protocol for the AELC randomized controlled trial
- Author
-
Liu, Wu Yi, Lu, Da Jiang, Du, Xia Ming, Sun, Jian Qin, Ge, Jun, Wang, Ren Wei, Wang, Ru, Zou, Jun, Xu, Chang, Ren, Jie, Wen, Xin Fei, Liu, Yang, Cheng, Shumei, Tan, Xiao, Pekkala, Satu, Munukka, Eveliina, Wiklund, Petri, Chen, Yan Qiu, Gu, Qing, Xia, Zheng Chang, Liu, Jun Jun, Liu, Wen Bin, Chen, Xue Bo, Zhang, Yi Min, Li, Rui, Borra, Ronald J H, Yao, Jia Xin, Chen, Pei Jie, and Cheng, Sulin
- Subjects
rasva-aineenvaihdunta ,gut microbiota ,glucose metabolism ,clinical setting ,metabonomics ,human ,liver fat content - Abstract
Background. Pre-diabetes and non-alcoholic fatty liver disease (NAFLD) are associated with an unhealthy lifestyle and pose extremely high costs to the healthcare system. In this study, we aim to explore whether individualized aerobic exercise (AEx) and low carbohydrate diet (LCh) intervention affect hepatic fat content (HFC) in pre-diabetes via modification of gut microbiota composition and other post-interventional effects. Methods/design. A 6-month randomized intervention with 6-month follow-up is conducted from January 2013 to December 2015. The target sample size for intervention is 200 postmenopausal women and middle-aged men aged 50–65 year-old with pre-diabetes and NAFLD. The qualified subjects are randomized into 4 groups with 50 subjects in each group: 1 = AEx, 2 = LCh, 3 = AEx + LCh, and 4 = control. In addition, two age-matched reference groups (5 = pre-diabetes without NAFLD (n = 50) and 6 = Healthy without pre-diabetes or NAFLD (n = 50)) are included. The exercise program consists of progressive and variable aerobic exercise (intensity of 60 to 75% of initial fitness level, 3–5 times/week and 30–60 min/time). The diet program includes dietary consultation plus supplementation with a special lunch meal (40% of total energy intake/day) which aims to reduce the amount of carbohydrate consumption (30%). The control and reference groups are advised to maintain their habitual habits during the intervention. The primary outcome measures are HFC, serum metabolomics and gut microbiota composition. The secondary outcome measures include body composition and cytokines. In addition, socio-psychological aspects, social support, physical activity and diet will be performed by means of questionnaire and interview. Discussion. Specific individualized exercise and diet intervention in this study offers a more efficient approach for liver fat reduction and diabetes prevention via modification of gut microbiota composition. Besides, the study explores the importance of incorporating fitness assessment and exercise in the management of patients with pre-diabetes and fatty liver disorders. If our program is shown to be effective, it will open new strategies to combat these chronic diseases. peerReviewed
- Published
- 2014
22. Probiotics and atherosclerosis – a new challenge?
- Author
-
Hani El-Nezami, Pirkka V. Kirjavainen, Chan Yee Kwan, and Chen Yan
- Subjects
education.field_of_study ,gut microbiota ,Cell adhesion molecule ,VSL#3 ,Population ,LGG ,Inflammation ,Biology ,Gut flora ,biology.organism_classification ,Fff Probiotics 2012 - Abstracts ,Proinflammatory cytokine ,Microbiology ,Supplement 2, 2012 ,ApoE−/− mice ,TLR2 ,cardiovascular disease ,TLR4 ,medicine ,medicine.symptom ,education ,ApoE-/- mice ,Selectin - Abstract
Background: Atherosclerosis is the major cause of cardiovascular disease and stroke, which are among the top 10 leading causes of death worldwide. Pathogen-associated molecular patterns (PAMPs) can activate toll-like receptors (TLRs) and activate nuclear factor kappa B (NFκB) signaling, a central pathway in inflamma...
- Published
- 2012
23. Probiotics and atherosclerosis – a new challenge?
- Author
-
Chan Yee Kwan, Pirkka Kirjavainen, Chen Yan, and Hani El-Nezami
- Subjects
gut microbiota ,cardiovascular disease ,ApoE−/− mice ,VSL#3 ,LGG ,lcsh:QR100-130 ,lcsh:Microbial ecology - Abstract
Background Atherosclerosis is the major cause of cardiovascular disease and stroke, which are among the top 10 leading causes of death worldwide. Pathogen-associated molecular patterns (PAMPs) can activate toll-like receptors (TLRs) and activate nuclear factor kappa B (NFκB) signaling, a central pathway in inflammation, which regulates genes that encode proinflammatory molecules essential in atherogenesis. Lipopolysaccharides (LPS), which is unique to gram negative bacteria, as well as peptidoglycan (PGN), which is found in gram positive bacteria are PAMPS and ligands of TLR4 and TLR2, respectively, both of which are essential in plaque progression in atherosclerosis. Gastrointestinal tract is suggested to be the major site for absorption and translocation of TLR2 and TLR4 stimulants. Inflammation can result in a ‘leaky gut’ that leads to higher bacterial translocation, eventually the accumulation of LPS and PGN would activate TLRs and trigger inflammation through NFκB and promote further systemic complication like atherosclerosis. Probiotics, can protect the intestinal barrier to reduce bacterial translocation and have potential systemic anti-inflammatory properties.To evaluate whether probiotics can help reduce atherosclerotic development using in vivo study.Apolipoprotein E knockout (ApoE−/ − ) mice were fed on high fat diet alone, with telmisartan (Tel) (1 or 5 mg/kg/day, positive controls) or with probiotics (VSL#3/LGG) with or without Tel (1 mg/kg/day) for 12 weeks.Probiotics, Tel, or a combination of both reduced lesion size at the aortic root significantly; VSL#3 reduced serum inflammatory adhesion molecules soluble E- (sE-)selectin, soluble intercellular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1 (sVCAM-1), and plaque disrupting factor matrix metalloproteinase (MMP)-9 significantly; probiotics and Tel at 5 mg/kg/day could induce changes in gut microbiota population; the efficiency of lesion reduction seemed to correlate to the microbiota composition; probiotics seemed to reduce plasma endotoxin but did not reach statistical significance.Probiotics has the potential to be used as a cheap, non-invasive, and with little side effects way to reduce atherosclerosis that brings worldwide benefits.
- Published
- 2012
24. Aspergillus niger fermented Tartary buckwheat ameliorates obesity and gut microbiota dysbiosis through the NLRP3/Caspase-1 signaling pathway in high-fat diet mice.
- Author
-
Huang, Yuzhe, Zhang, Kunfeng, Guo, Wenqiang, Zhang, Chan, Chen, Hao, Xu, Tenglong, Lu, Yongming, Wu, Qingxi, Li, Yong, and Chen, Yan
- Abstract
[Display omitted] • Fermented Tartary buckwheat dietary fiber was prepared using Aspergillus niger for the first time. • Liquid fermentation improves the content of soluble dietary fiber in Tartary buckwheat. • Liquid fermentation changes the physicochemical properties of Tartary buckwheat soluble dietary fiber, such as water holding capacity, oil holding capacity, water swelling capacity, and cholesterol adsorption capacity. • Fermented Tartary buckwheat dietary fiber has excellent anti-obesity activity. • Fermented Tartary buckwheat dietary fiber regulates the composition of intestinal flora and inhibits obesity in HFD mice. Tartary buckwheat is a popular natural grain commonly used as a functional food in various countries. This study aimed to prepare buckwheat dietary fiber with improved biological activity using liquid fermentation of Aspergillus niger and to elucidate its physicochemical properties and related mechanisms. Compared with unfermented buckwheat dietary fiber, Aspergillus niger fermentation increased the soluble dietary fiber content, thereby improving dietary fiber's physical and chemical properties such as water, oil retention capacity, and swelling cholesterol-binding capacity. Fermented Tartary buckwheat dietary fiber treatment for 14 weeks significantly decreased the hepatic lipid profile, oxidative stress, and protein expression in mice. In addition, fermented Tartary buckwheat dietary fiber intervention could regulate high-fat diet-induced disorders of gut microbiota. These results suggested that fermented Tartary buckwheat dietary fiber has potential "prebiotic" effects in ameliorating obesity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men – the role of gut microbiota composition: study protocol for the AELC randomized controlled trial
- Author
-
Liu, Wu Yi, Lu, Da Jiang, Du, Xia Ming, Sun, Jian Qin, Ge, Jun, Wang, Ren Wei, Wang, Ru, Zou, Jun, Xu, Chang, Ren, Jie, Wen, Xin Fei, Liu, Yang, Cheng, Shu Mei, Tan, Xiao, Pekkala, Satu, Munukka, Eveliina, Wiklund, Petri, Chen, Yan Qiu, Gu, Qing, Xia, Zheng Chang, Liu, Jun Jun, Liu, Wen Bin, Chen, Xue Bo, Zhang, Yi Min, Li, Rui, Borra, Ronald J H, Yao, Jia Xin, Chen, Pei Jie, and Cheng, Sulin
- Subjects
Liver fat content ,Glucose metabolism ,Lipid metabolism ,Gut microbiota ,Metabonomics ,Human ,Clinical setting - Abstract
Background: Pre-diabetes and non-alcoholic fatty liver disease (NAFLD) are associated with an unhealthy lifestyle and pose extremely high costs to the healthcare system. In this study, we aim to explore whether individualized aerobic exercise (AEx) and low carbohydrate diet (LCh) intervention affect hepatic fat content (HFC) in pre-diabetes via modification of gut microbiota composition and other post-interventional effects. Methods/design A 6-month randomized intervention with 6-month follow-up is conducted from January 2013 to December 2015. The target sample size for intervention is 200 postmenopausal women and middle-aged men aged 50–65 year-old with pre-diabetes and NAFLD. The qualified subjects are randomized into 4 groups with 50 subjects in each group: 1 = AEx, 2 = LCh, 3 = AEx + LCh, and 4 = control. In addition, two age-matched reference groups (5 = pre-diabetes without NAFLD (n = 50) and 6 = Healthy without pre-diabetes or NAFLD (n = 50)) are included. The exercise program consists of progressive and variable aerobic exercise (intensity of 60 to 75% of initial fitness level, 3–5 times/week and 30–60 min/time). The diet program includes dietary consultation plus supplementation with a special lunch meal (40% of total energy intake/day) which aims to reduce the amount of carbohydrate consumption (30%). The control and reference groups are advised to maintain their habitual habits during the intervention. The primary outcome measures are HFC, serum metabolomics and gut microbiota composition. The secondary outcome measures include body composition and cytokines. In addition, socio-psychological aspects, social support, physical activity and diet will be performed by means of questionnaire and interview. Discussion Specific individualized exercise and diet intervention in this study offers a more efficient approach for liver fat reduction and diabetes prevention via modification of gut microbiota composition. Besides, the study explores the importance of incorporating fitness assessment and exercise in the management of patients with pre-diabetes and fatty liver disorders. If our program is shown to be effective, it will open new strategies to combat these chronic diseases. Trial registration Current Controlled Trials: ISRCTN42622771.
- Published
- 2014
- Full Text
- View/download PDF
26. Lactobacillus plantarum AR113 alleviates DSS-induced colitis by regulating the TLR4/MyD88/NF-κB pathway and gut microbiota composition.
- Author
-
Xia, Yongjun, Chen, Yan, Wang, Guangqiang, Yang, Yijin, Song, Xin, Xiong, Zhiqiang, Zhang, Hui, Lai, Phoency, Wang, Shijie, and Ai, Lianzhong
- Abstract
• L. plantarum AR113 could alleviate symptoms of colitis and prevent tissue damage effectively. • L. plantarum AR113 could maintains intestinal barrier by recover goblet cell and tight junction. • HO-1 upregulated could inhibit TLR4/MyD88/NF-κB pathway and reduce pro-inflammatory factors. • L. plantarum AR113 could mitigate dysbiosis of gut microbiota induced by DSS. Probiotics are a potential treatment agent for IBD. In this study, the effects of probiotics on intestinal immune responses and gut microbiota in colitis were investigated. The result showed that L. plantarum AR113 and L. casei AR342 were 2–3 times more effective than other strains to alleviate epithelial damage indicators, improve colon length (+10–30%) and maintain the integrity of the epithelial barrier, as compared to DSS-treatment mice. The supplementation downregulated expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and upregulated that of the colonic anti-inflammatory cytokine (IL-10). The results strongly suggested that anti-inflammatory effect of probiotics is associated with the increase in HO-1 expression and the decrease in TLR4/MyD88/NF-κB pathway expression in mouse colonic tissues. Further, Microbiota analysis and the correlation of microbiota with colitis parameters revealed that the dysbiosis of gut microbiota induced by DSS treatment could be mitigated to a certain extent by supplementation with L. plantarum AR113. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
27. Structural characteristics of a polysaccharide from Armillariella tabescens and its protective effect on colitis mice via regulating gut microbiota and intestinal barrier function.
- Author
-
Li, Yuan-Yuan, Sun, Jing-Wen, Chen, Lei, Lu, Yong-Ming, Wu, Qing-Xi, Yan, Chao, Chen, Yan, Zhang, Mei, and Zhang, Wen-Na
- Subjects
- *
INTESTINAL barrier function , *SHORT-chain fatty acids , *ULCERATIVE colitis , *TIGHT junctions , *POLYSACCHARIDES , *OCCLUDINS - Abstract
A new polysaccharide fraction (ATP) was obtained from Armillariella tabescens mycelium. Structural analysis suggested that the backbone of ATP was →4)- α -D-Glc p (1 → 2)- α -D-Gal p (1 → 2)- α -D-Glc p (1 → 4)- α -D-Glc p (1→, which branched at O-3 of →2)- α -D-Glc p (1 → and terminated with T- α -D-Glc p or T- α -D-Man p. Besides, ATP significantly alleviated ulcerative colitis (UC) symptoms and inhibited the production of pro-inflammation cytokines (IL-1 β , IL-6). Meanwhile, ATP could improve colon tissue damage by elevating the expression of MUC2 and tight junction proteins (ZO-1, occludin and claudin-1) levels and enhance intestinal barrier function through inhibiting the activation of MMP12/MLCK/ p -MLC2 signaling pathway. Further studies exhibited that ATP could increase the relative abundance of beneficial bacteria such as f. Muribaculacese , g. Muribaculaceae , and g. Alistips , and decrease the relative abundance of g. Desulfovibrio , g. Colidextribacter , g. Ruminococcaceae and g.Oscillibacter , and regulate the level of short-chain fatty acids. Importantly, FMT intervention with ATP-derived microbiome certified that gut microbiota was involved in the protective effects of ATP on UC. The results indicated that ATP was potential to be further developed into promising therapeutic agent for UC. [Display omitted] • A new polysaccharide of Armillariella tabescens (ATP) was purified and characterized. • ATP significantly alleviated UC symptoms and regulated inflammatory response. • ATP improved the integrity of intestinal epithelial barrier in UC mice. • ATP could modulate gut microbiota and SCFAs levels. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Extraction, purification, structural characterization, and gut microbiota relationship of polysaccharides: A review.
- Author
-
Huang, Yuzhe, Chen, Hao, Zhang, Kunfeng, Lu, Yongming, Wu, Qianzheng, Chen, Jielin, Li, Yong, Wu, Qingxi, and Chen, Yan
- Subjects
- *
GUT microbiome , *POLYSACCHARIDES , *NON-alcoholic fatty liver disease , *CHEMICAL processes , *CHEMICAL purification , *METABOLIC syndrome - Abstract
Intestinal dysbiosis is one of the major causes of the occurrence of metabolic syndromes, such as obesity, diabetes, nonalcoholic fatty liver disease, and cardiovascular diseases. Polysaccharide-based microbial therapeutic strategies have excellent potential in the treatment of metabolic syndromes, but the underlying regulatory mechanisms remain elusive. Identification of the internal regulatory mechanism of the gut microbiome and the interaction mechanisms involving bacteria and the host are essential to achieve precise control of the gut microbiome and obtain valuable clinical data. Polysaccharides cannot be directly digested; the behavior in the intestinal tract is considered a "bridge" between microbiota and host communication. To provide a relatively comprehensive reference for researchers in the field, we will discuss the polysaccharide extraction and purification processes and chemical and structural characteristics, focusing on the polysaccharides in gut microbiota through the immune system, gut-liver axis, gut-brain axis, energy axis interactions, and potential applications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
29. Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice
- Author
-
Xiuxiu Xu, Siyuan Sun, Ling Liang, Chenxi Lou, Qijin He, Maojuan Ran, Lu Zhang, Jingyue Zhang, Chen Yan, Hengjie Yuan, Lu Zhou, Xin Chen, Xin Dai, Bangmao Wang, Jie Zhang, and Jingwen Zhao
- Subjects
NAFLD ,AHR ,indole-3-acetic acid ,sulforaphane ,gut microbiota ,high-fat diet ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Scope: Gut microbiome-derived metabolites are the major mediators of diet-induced host-microbial interactions. Aryl hydrocarbon receptor (AHR) plays a crucial role in glucose, lipid, and cholesterol metabolism in the liver. In this study, we aimed to investigate the role of indole-3-acetic acid (IAA) and AHR in sulforaphane (SFN) alleviates hepatic steatosis in mice fed on a high-fat diet (HFD).Methods and Results: The HFD-fed male C57BL/6 mice were intervened with SFN for 6 weeks. HFD-mice showed classical pathophysiological characteristics of hepatic steatosis. The results showed that SFN significantly reduced body weight, liver inflammation and hepatic steatosis in HFD-fed mice. SFN reduced hepatic lipogenesis by activating AHR/SREBP-1C pathway, which was confirmed in HepG2 cell experiments. Moreover, SFN increased hepatic antioxidant activity by modulating Nrf-2/NQO1 expression. SFN increased serum and liver IAA level in HFD mice. Notably, SFN manipulated the gut microbiota, resulting in reducing Deferribacteres and proportions of the phylum Firmicutes/Bacteroidetes and increasing the abundance of specific bacteria that produce IAA. Furthermore, SFN upregulated Ahr expression and decreased the expression of inflammatory cytokines in Raw264.7 cells.Conclusions: SFN ameliorated hepatic steatosis not only by modulating lipid metabolism via AHR/SREBP-1C pathway but regulating IAA and gut microbiota in HFD-induced NAFLD mice.
- Published
- 2021
- Full Text
- View/download PDF
30. Attenuation effect of a polysaccharide from large leaf yellow tea by activating autophagy.
- Author
-
Chen, Hao, Wang, Zhuang, Gong, Lei, Chen, Jielin, Huang, Yuzhe, Guo, Wenqiang, Zhang, Qiang, Li, Yong, Bao, Guanhu, Li, Daxiang, and Chen, Yan
- Subjects
- *
POLYSACCHARIDES , *AUTOPHAGY , *ANTINEOPLASTIC agents , *GUT microbiome , *TEA , *IRINOTECAN , *EPIGALLOCATECHIN gallate - Abstract
Chemotherapy, the most common class of anticancer drugs, is considerably limited owing to its adverse side effects. In this study, we aimed to evaluate the protective effect and mechanism of action of large-leaf yellow tea polysaccharides (ULYTP-1, 1.29 × 104 Da) against chemotherapeutic 5-fluorouracil (5-Fu). Structural characterisation revealed that ULYTP-1 was a β-galactopyranouronic acid. Furthermore, ULYTP-1 promoted autolysosome formation, activating autophagy and reducing the oxidative stress and inflammation caused by 5-Fu. Our in vivo study of 4 T1 tumour-bearing mice revealed that ULYTP-1 also attenuated 5-Fu toxicity through modulation of the gut microbiota. Moreover, ULYTP-1 effectively protected immune organs and the liver from 5-Fu toxicity, while promoting its tumour-inhibitory properties. The current findings provide a new strategy for optimising chemotherapy regimens in the clinic. [Display omitted] • Polysaccharide ULYTP-1 was extracted from large-leaf yellow tea. • ULYTP-1 is a β-galactopyranouronic acid with a spongy steric configuration. • ULYTP-1 activates autophagy to alleviate 5-fluorouracil-induced liver injury. • ULYTP-1 alleviated gut dysbiosis in 4 T1 tumour-bearing mice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis.
- Author
-
Yang, Junling, Dong, Huibin, Wang, Ya, Jiang, Yun, Zhang, Wenna, Lu, Yongming, Chen, Yan, and Chen, Lei
- Subjects
- *
DIABETIC nephropathies , *RENAL fibrosis , *GUT microbiome , *CICADAS , *POLYSACCHARIDES , *CORDYCEPS , *RIBOSOMAL RNA - Abstract
Diabetic nephropathy (DN), a complication of diabetes mellitus, has been the leading cause of death in people with chronic kidney disease. This study was conducted to examine the potential health benefits of Cordyceps cicadae polysaccharides (CCP) on kidney injury and renal interstitial fibrosis that occur in DN rats. First, a DN model was established using SD rats fed with a high-fat diet for 8 weeks, then injected with STZ (35 mg/kg) intraperitoneally. The rats were then supplemented with CCP (75, 150 and 300 mg/kg) for 4 weeks. The results indicated that CCP improve insulin resistance and glucose tolerance in DN rats. Furthermore, CCP intervention significantly suppressed the inflammation, renal pathological changes and renal dysfunction, slowing down the progression of renal interstitial fibrosis. Moreover, high-throughput pyrosequencing of 16S rRNA suggested that CCP modulated the dysbiosis of gut microbiota by enhancing the relative abundance and proliferation capacity of probiotics. In vitro, CCP can markedly decrease LPS-induced inflammatory cytokine levels and TGF-β1-induced fibroblast activation. In summary, the results provided evidence that CCP exerted a beneficial effect on tubulointerstitial fibrosis in DN rats by possibly suppressing the inflammatory response and modulating gut microbiota dysbiosis, via blocking the TLR4/NF-κB and TGF-β1/Smad signaling pathway. Unlabelled Image [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives
- Author
-
Chen Yan, Cuili Zhang, Xuejiao Cao, Bin Feng, and Xinli Li
- Subjects
chitosan ,chitosan oligosaccharides ,gut microbiota ,metabolic syndrome ,Organic chemistry ,QD241-441 - Abstract
Chitosan and its derivatives can alleviate metabolic syndrome by different regulation mechanisms, phosphorylation of AMPK (AMP-activated kinase) and Akt (also known as protein kinase B), suppression of PPAR-γ (peroxisome proliferator-activated receptor-γ) and SREBP-1c (sterol regulatory element–binding proteins), and translocation of GLUT4 (glucose transporter-4), and also the downregulation of fatty-acid-transport proteins, fatty-acid-binding proteins, fatty acid synthetase (FAS), acetyl-CoA carboxylase (acetyl coenzyme A carboxylase), and HMG-CoA reductase (hydroxy methylglutaryl coenzyme A reductase). The improved microbial profiles in the gastrointestinal tract were positively correlated with the improved glucose and lipid profiles in hosts with metabolic syndrome. Hence, this review will summarize the current literature illustrating positive correlations between the alleviated conditions in metabolic syndrome hosts and the normalized gut microbiota in hosts with metabolic syndrome after treatment with chitosan and its derivatives, implying that the possibility of chitosan and its derivatives to serve as therapeutic application will be consolidated. Chitosan has been shown to modulate cardiometabolic symptoms (e.g., lipid and glycemic levels, blood pressure) as well as gut microbiota. However, the literature that summarizes the relationship between such metabolic modulation of chitosan and prebiotic-like effects is limited. This review will discuss the connection among their structures, biological properties, and prebiotic effects for the treatment of metabolic syndrome. Our hope is that future researchers will consider the prebiotic effects as significant contributors to the mitigation of metabolic syndrome.
- Published
- 2020
- Full Text
- View/download PDF
33. Time-dependent laxative effect of sennoside A, the core functional component of rhubarb, is attributed to gut microbiota and aquaporins.
- Author
-
Zhang, Mei-Mei, Gong, Zhi-Cheng, Zhao, Qi, Xu, Ding-Qiao, Fu, Rui-Jia, Tang, Yu-Ping, and Chen, Yan-Yan
- Subjects
- *
LAXATIVES , *QUINONE , *REVERSE transcriptase polymerase chain reaction , *MEDICINAL plants , *DNA , *SEQUENCE analysis , *GUT microbiome , *TIME , *ANIMAL experimentation , *DISCRIMINANT analysis , *FECES , *PLANT extracts , *MEMBRANE proteins , *LACTOBACILLUS , *MICE - Abstract
Ethnopharmacological relevance : Sennoside A is a natural anthraquinone component mainly derived from rhubarb and has been routinely used as a clinical stimulant laxative. However, long-term application of sennoside A may lead to drug resistance and even adverse reactions, thus limiting its clinical use. Therefore, to reveal the time-dependent laxative effect and potential mechanism of sennoside A is of critical importance. Aim of the study : This study was conducted to investigate the time-dependent laxative effect of sennoside A and unveil its underlying mechanism from the perspective of gut microbiota and aquaporins (AQPs). Materials and methods : Based on a mouse constipation model, 2.6 mg/kg sennoside A was administered orally for 1, 3, 7, 14 and 21 days, respectively. The laxative effect was assessed by the fecal index and fecal water content, the histopathology of the small intestine and colon was evaluated by hematoxylin-eosin staining. Gut microbiota changes was observed by 16S rDNA sequencing, and colonic AQPs expression was analyzed by quantitative real-time polymerase chain reaction and western blotting. Partial least-squares regression (PLSR) was used to screen out the effective indicators contributing to the laxative effect of sennoside A. The effective indicators were then fitted to time by a drug-time curve model to analyze the trend of efficacy of sennoside A, and the optimal time of administration was derived by comprehensive analysis with a three-dimensional (3D) time-effect image. Results : Sennoside A had a significant laxative effect at 7 days of administration with no pathological changes in the small intestine or colon; however, at 14 or 21 days of administration, the laxative effect diminished and slight damage to the colon was observed. Sennoside A affects the structure and function of gut microbes. The alpha diversity showed that the abundance and diversity of gut microorganisms reached the highest value after 7 days of administration. Partial least squares discriminant analysis showed that the composition of the flora was close to normal when administered for less than 7 days, but was closest to the composition of constipation over 7 days. The expression of aquaporin 3 (AQP3) and aquaporin 7 (AQP7) decreased gradually after the administration of sennoside A, with the lowest expression at 7 days, and then increased gradually afterwards, while the expression of aquaporin 1 (AQP1) was the opposite. The PLSR results showed that AQP1, AQP3, Lactobacillus , Romboutsia , Akkermansia and UCG_005 contributed more to the laxative effect of the fecal index, and after fitting with the drug-time curve model, each index showed a trend of increasing and then decreasing. The comprehensive evaluation of the 3D time-effect image concluded that the laxative effect of sennoside A reached its best after 7 days of administration. Conclusion : Sennoside A should be used in regular dosages for less than one week, as it provides significant relief of constipation and exhibits no colonic damage within 7 days of administration. In addition, Sennoside A exerts its laxative effect by regulating gut microbiota of Lactobacillus Romboutsia , Akkermansia and UCG_005 and water channels of AQP1 and AQP3. [Display omitted] • For constipation relief, Sennoside A should be used at regular dose for less than 7 days. • Sennoside A exerts the laxative effect by regulating gut microbiota and aquaporins. • The optimal time is obtained through a comprehensive analysis of fecal index, intestinal histopathology, gut microbiota and aquaporins. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Polysaccharide ORP-1 isolated from Oudemansiella raphanipes ameliorates age-associated intestinal epithelial barrier dysfunction in Caco-2 cells monolayer.
- Author
-
Pan, Wen-Juan, Shi, Lu-Lu, Ren, Yu-Ru, Yao, Cheng-Ying, Lu, Yong-Ming, and Chen, Yan
- Subjects
- *
LACTOBACILLUS acidophilus , *POLYSACCHARIDES , *ESCHERICHIA coli , *INTESTINES , *BIFIDOBACTERIUM bifidum , *PROTEIN expression , *TIGHT junctions - Abstract
ORP-1 can restore a healthy gut microbial population to handle age-related gut microbiota dysbiosis mainly by facilitating the proliferation and adhesion of intestinal probiotics L. acidophilus and B. bifidum in the colon to compete with pathogenic microbes E. coli for ecological niches. Furthermore, ORP-1 strengthened the intestinal structural integrity primarily by abolishing the aggravation of apoptosis and the age-associated alterations of TJ protein expression in intestine. [Display omitted] • ORP-1 is a novel bioactive component of edible fungus Oudemansiella raphanipes. • ORP-1 facilitates the adhesion of probiotics to compete with intestinal pathogenic. • ORP-1 abolishes the aggravation of apoptosis and heightened intestinal structural integrity. • ORP-1 strengthens intestinal barrier integrity by abolishing TJ proteins and mRNA expression. Age-associated increase in intestinal permeability is known to relate with gut microbiota dysbiosis and loss of epithelial tissue integrity. To improve healthy aging and prevent age-associated chronic disabilities, the protective potential of polysaccharides from Oudemansiella raphanipes (ORP-1) against age-associated intestinal epithelial barrier dysfunction in d -galactose-induced Caco-2 cells monolayer was investigated. In-vitro results demonstrated that ORP-1 can restore a healthy gut microbial population to handle age-related gut microbiota dysbiosis mainly by facilitating the proliferation and adhesion of probiotics Lactobacillus acidophilus (L. acidophilus) and Bifidobacterium bifidum (B. bifidum) to compete with intestinal pathogenic Escherichia coli (E. coli) for ecological niches and nutrition. Meanwhile, ORP-1 strengthened the intestinal structural integrity primarily by abolishing the aggravation of apoptosis and the age-associated alterations of tight junction (TJ) proteins expression in intestine. These findings highlighted that ORP-1 could be a potential functional food component with preventive utility against age-associated intestinal barrier injury. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. Sex differences in growth performance are related to cecal microbiota in chicken.
- Author
-
Cui, Lei, Zhang, Xiaolong, Cheng, Ranran, Ansari, Abdur Rahman, Elokil, Abdelmotaleb A., Hu, Yafang, Chen, Yan, Nafady, Abdallah A., and Liu, Huazhen
- Subjects
- *
CHICKENS , *LIPID metabolism , *LEG muscles , *GUT microbiome , *LIVER analysis , *BACTEROIDES fragilis - Abstract
In poultry industry, male chickens have a better growth performance than female ones under the same genetic background and diet. Emerging evidences proposed an important role of intestinal microbiota in chicken's growth performance. This study aimed to determine gut microbiota related gender based differences in the growth performance of chickens. Therefore, male and female chickens (n = 20) at 7-week age were used to carry out histomorphological, molecular, gene expression analysis with their liver, chest and leg muscle, as well as 16S rRNA sequencing analysis for gut microbiota. The results revealed that Bacteroides and Megamonas genera were more prominently colonized in the cecum of male chickens. The male chicken's cecal microbiota indicated a closer relation with glycan metabolism, while in the female chickens it was more related with lipid metabolism. Gene expression levels associated with glycan and lipid metabolism were different between male and female chickens. Further, using Spearman correlation analysis, we found a positive correlation between glycan and lipid metabolism, and the relative abundance of Bacteroides, Megamona and Lactobacillus in male chickens. Similarly, we also found a positive correlation between the lipid metabolism and the relative abundance of Ruminococcaceae and Enterococcus in female chickens. These findings revealed the association of chicken growth performance with cecal microbiota that contributed to the metabolism of glycan and lipid in a sex-dependent manner. • A significant difference was observed in growth performance between male and female chickens. • Cecal microbiota significantly participated in glycan and lipid metabolism. • There might be a novel interaction in the mechanisms of probiotic and microbiome-host for poultry production. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
36. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.
- Author
-
Yue, Shi-Jun, Wang, Wen-Xiao, Yu, Jin-Gao, Chen, Yan-Yan, Shi, Xu-Qin, Yan, Dan, Zhou, Gui-Sheng, Zhang, Li, Wang, Chang-Yun, Duan, Jin-Ao, and Tang, Yu-Ping
- Subjects
- *
CHINESE medicine , *GUT microbiome , *DEVELOPMENTAL biology , *NUCLEOTIDE sequencing - Abstract
With the development of system biology, traditional Chinese medicine (TCM) is drawing more and more attention nowadays. However, there are still many enigmas behind this ancient medical system because of the arcane theory and complex mechanism of actions. In recent decades, advancements in genome sequencing technologies, bioinformatics and culturomics have led to the groundbreaking characterization of the gut microbiota, a 'forgotten organ', and its role in host health and disease. Notably, gut microbiota has been emerging as a new avenue to understanding TCM. In this review, we will focus on the structure, composition, functionality and metabolites of gut microbiota affected by TCM so as to conversely understand its theory and mechanisms. We will also discuss the potential areas of gut microbiota for exploring Chinese material medica waste, Chinese marine material medica, add-on therapy and personalized precise medication of TCM. The review will conclude with future perspectives and challenges of gut microbiota in TCM intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.